Open access
Jul 2026
DUSP5 contributes to platinum resistance in ovarian cancer: single-cell discovery and functional validation
Findings support DUSP5 as a candidate biomarker and therapeutic target that warrants further mechanistic and clinical validation and contribute to platinum response and resistance by linking tumor-intrinsic adaptive programs with TME-associated features in ovarian cancer.
Cheng-Feng Liu, Wehua Li, Tingjun Liao et al.
· Frontiers in Pharmacology · 0 citations